At the European Association of Nuclear Medicine Congress, researchers revealed that metabolically active visceral fat contributes to more aggressive endometrial cancer phenotypes. This finding shifts focus from obesity as a mere risk factor to the biological activity of fat tissue influencing tumor behavior. Insights from this study open potential avenues for targeted imaging and therapeutic strategies addressing cancer metabolism.